The GPER-mediated CAF-dependent estrogenic effects in the tumor-associated stroma are more likely to contribute to breast cancer progression, especially in the tamoxifen resistance, via a positive feedback loop involving the GPER/EGFR/ERK signaling pathway and E2 production. This evidence concerns the gene EGFR and breast cancer.